Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12

Drug Research

Volumn 63, Issue 1, 2013, Pages 7-12

  Nahaei, M ^a   Valizadeh, H ^b   Baradaran, B ^c   Nahaei, M R ^d   Asgari, D ^b   Hallaj Nezhadi, S ^a   Dastmalchi, S ^e   Lotfipour, F ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

chitosan; interleukin 12; nanoparticle; plasmid; cyclodextrin

Indexed keywords

ALDEVRON; BETA CYCLODEXTRIN; CHITOSAN; INTERLEUKIN 12; NANOCARRIER; PLASMID DNA; UNCLASSIFIED DRUG; BETA CYCLODEXTRIN DERIVATIVE; CHITOSAN BETA CYCLODEXTRIN; CHITOSAN-BETA-CYCLODEXTRIN; DNA; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; GELATION; IMMUNOGENICITY; IN VITRO GENE TRANSFER; IONIC STRENGTH; MOLECULAR WEIGHT; NANOENCAPSULATION; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; VISCOSITY; ZETA POTENTIAL; ANIMAL; GENETIC TRANSFECTION; GENETICS; MOUSE; PLASMID; TUMOR CELL LINE;

ANIMALS; BETA-CYCLODEXTRINS; CELL LINE, TUMOR; CHITOSAN; DNA; INTERLEUKIN-12; MICE; MOLECULAR WEIGHT; NANOPARTICLES; PLASMIDS; TRANSFECTION;

MLCS; MLOWN;

EID: 84878888425     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0032-1331165     Document Type: Article

References (26)

1. Hallaj-Nezhadi S., Valizadeh H., Dastmalchi S. et al. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells. J Pharm Pharm Sci: 2011; 14 181 195
2. George J. A. Gene therapy progress and prospects: Adenoviral vectors. Gene ther: 2003; 10 1135 1141
3. Schmidt-Wolf G. D., Schumidt-Wolf IG H. Non-viral and hybrid vectors in human gene therapy: An update. Trends Mol Med: 2003; 9 67 72
4. Davis M. E. Non-viral gene delivery systems. Curr Opin Biotech: 2002; 13 128 131
5. Al-Dosari M. S., Gao X. Nonviral gene delivery: Principle, limitations and recent progress. AAPS: 2009; 11 671 681
6. Morille M., Passirani C., Vonarbourg A. et al. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials: 2008; 29 3477 3496
7. Teijeiro-Osorio D., Remunan-Lopez C., Alonso M. J. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur J Pharm Biopharm: 2009; 71 02 257 263
8. Arun R., Ashok KC K., Sravanti VVNS S. Cuclodextrins as drug carrier molecule: A review. Scientia Pharmaceutica: 2008; 76 567 598
9. Zhang J. T., Chua L. S., Lynn D. M. Multilayer thin films that sustain the release of functional DNA under physiological conditions. Langmuir: 2004; 20 19 8015 8021
10. Jessel N., Oulad-Abdelghani M., Meyer F. et al. Multiple and time-scheduled in situ DNA delivery mediated be beta-cyclodextrin embedded in a polyelectolyte multilayer. Proc Nat Acad Sci USA: 2006; 103 23 8618 8621
11. Irie T., Otagiri M., Sunada M. et al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J Pharmacobiodyn: 1982; 5 09 741 744
12. Kilsdonk EP C., Yancey P. G., Stoudt G. W. et al. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem: 1995; 270 29 17250 17256
13. Cryan S. A., Holohan A., Donohue R. et al. Cell transfection with polycationic cyclodextrine vectors. Eur J Pharm Sci: 2004; 21 05 625 633
14. Mao S., Shuai X., Unger F. et al. The depolymerization of chitosan: Effects on physicochemical and biological properties. Int J Pharm: 2004; 281 1-2 45 54
15. Wang W., Bo S., Li S. et al. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int J Biol Macromol: 1991; 13 05 281 285
16. Mao H. Q., Roya K., Troung-Le V. L. et al. Chitosan-DNA nanoparticles as gene carrier: Synthesis, characterization and transfection efficiency. J Controlled Release: 2001; 70 03 399 421
17. Tan J., Newton C. A., Djeu J. Y. et al. Unjection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. P Am Assoc Canc Res: 1996; 56 3399 3403
18. Diez S., Migueliz I., Ilarduya CT. Targeted cationic poly (D,L-lactic-co-glycolic acid) nanoparticles for gene delivery to cultured cells. Cell Mol Biol Lett: 2009; 14 02 347 362
19. Ranaldi G., Mariglianoa I., Vespignani I. et al. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line. J Nutr Biochem: 2002; 13 03 157 167
20. Bowman K., Leong K. W. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine: 2006; 1 02 117 128
21. Csaba N., Kping-Hggard M., Alonso M. J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm: 2009; 382 205 214
22. Li X. W., Lee DK L., Chan AS C. et al. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochim Biophys Acta: 2003; 1630 01 7 18
23. Maeda Y., Kimura Y. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr: 2004; 134 04 945 950
24. Dhiman H. K., Ray A. R., Panda A. K. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials: 2005; 26 09 979 986
25. Qi L. F., Xu Z. R., Li Y. et al. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroentero: 2005; 11 33 5136 5141
26. Nge K. L., Nitar N., Chandrkrachang S. et al. Chitosan as a growth stimulator in orchid tissue culture. Plant Sci: 2006; 170 1185 1190